Publication details

Farmakoekonomické hodnocení cetuximabu a panitumumabu v 1. linii léčby mCRC v reálné klinické praxi ČR

Title in English The Pharmacoeconomic Analysis of Cetuximab and Panitumumab in the 1st Line Treatment of mCRC in Real Clinical Practice in the Czech Republic.
Authors

SEHNALOVÁ Irena ŘÍHOVÁ Barbora NĚMEČEK Radim KINTROVÁ Kateřina DEMLOVÁ Regina

Year of publication 2019
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.linkos.cz/english-summary/klinicka-onkologie-journal/2019-08-15-4-en/farmakoekonomicke-hodnoceni-cetuximabu-a-panitumumabu-v-1-linii-lecby-mcrc-v-rea-1/
Doi http://dx.doi.org/10.14735/amko2019288
Keywords cetuximab; panitumumab; colorectal carcinoma; cost analysis
Description Cost and effectiveness analysis of EGFR inhibitors cetuximab or panitumumab in the first line treatment of metastatic colorectal cancer in the Czech Republic
Related projects: